Bone Biologics Corp (BBLG) News
Filter BBLG News Items
BBLG News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
BBLG News Highlights
- For BBLG, its 30 day story count is now at 3.
- Over the past 13 days, the trend for BBLG's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
Latest BBLG News From Around the Web
Below are the latest news stories about BONE BIOLOGICS CORP that investors may wish to consider to help them evaluate BBLG as an investment opportunity.
Bone Biologics Provides Scientific Update on NB1 Bone Graft DeviceBURLINGTON, Mass., September 26, 2023--Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, provides an update on its clinical development initiatives with its NB1 bone graft device. |
Insider Buying: CFO Deina Walsh Acquires 8,000 Shares of Bone Biologics Corp (BBLG)On September 13, 2023, Deina Walsh, the Chief Financial Officer (CFO) of Bone Biologics Corp (NASDAQ:BBLG), made a significant insider purchase of 8,000 shares of the company. |
CEO Jeff Frelick Buys 9,500 Shares of Bone Biologics Corp (BBLG)On September 11, 2023, Jeff Frelick, the CEO of Bone Biologics Corp (NASDAQ:BBLG), purchased 9,500 shares of the company, marking a significant insider buying activity. |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on FridayWe're starting the final day of trading this week with a dive into the biggest pre-market stock movers worth watching for Friday! |
BBLG Advances Crucial Technology and Solidifies FundingBy Brad Sorensen, CFA NASDAQ:BBLG READ THE FULL BBLG RESEARCH REPORT Bone Biologics (NASDAQ:BBLG) recently announced that it has received approval to begin pilot clinical trials with NB1 in spinal fusion patients. The approval was given by the Human Research Ethics Committee and the trials will take place in Australia. This is an important and exciting step for Bone as the study will evaluate the |
Why Is Bone Biologics (BBLG) Stock Down 52% Today?Bone Biologics (BBLG) stock is breaking down on Thursday after the company announced the details of a public share offering. |
Why Are Chinese Stocks BABA, JD, PDD Up Today?Chinese stocks are on the rise Thursday as investors react to Alibaba (BABA) expansion plans and lowered interest rates. |
Why Is OncoSec Medical (ONCS) Stock Down 48% Today?OncoSec Medical (ONCS) stock is falling hard on Thursday after the clinical-stage biotechnology company filed for bankruptcy. |
XPEV Stock Alert: Xpeng Expands Assisted Driving TechXpeng (XPEV) stock is on the move Thursday after the Chinese EV company expanded its assisted driving technology to Beijing. |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on ThursdayIt's time to start breaking down the biggest pre-market movers for Thursday as we get ready for another busy day of trading! |